SESSION TITLE: Lung Cancer: Diagnosis and Prognosis
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Saturday, April 16, 2016 at 09:45 AM - 11:15 AM
PURPOSE: The rationale of systemic therapy for locally advanced lung cancer is well understood. We evaluated various local-regional control (LRC) strategies for IIIA (N2) non-small cell lung cancer (NSCLC) by assessing the association between LRC and cancer-specific survival (CSS) in a retrospective population-based analysis from the Surveillance, Epidemiology, and End Results (SEER) database (1988 - 2012).